2-MDP
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C16H19NO |
Molar mass | 241.334 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
| |
NY (what is this?) (verify) |
2-MDP (U-23807A) is a dissociative anaesthetic drug which has been found to be an NMDA antagonist and produces similar effects to PCP in animals. The levo or (−) isomer is the active form of the drug.[1][2] It also has stimulant effects, having only around one third the potency of amphetamine by weight, but with a long duration of action, lasting more than 24 hours from a single oral dose.[3]
Effects
The therapeutic action is said to exhibit appetite suppressant and antidepressant[4] like activity.
Synthesis
In a variation of the nitrile-Aldol reaction (also demonstrated for venlafaxine), combination of benzophenone (1) and propionitrile (2), in the presence of sodamide base and ethyl ether solvent, leads to 3-hydroxy-2-methyl-3,3-diphenylpropanenitrile [6275-86-1] (3). The reduction of the intermediate nitrile group with lithium aluminium hydride completed the synthesis of U-23,807A (4).
References
- ^ Tang AH, Cangelosi AA, Code RA, Franklin SR (February 1984). "Phencyclidine-like behavioral effects of 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP)". Pharmacology, Biochemistry, and Behavior. 20 (2): 209–213. doi:10.1016/0091-3057(84)90244-2. PMID 6718449. S2CID 38908019.
- ^ Blake JC, Davies SN, Church J, Martin D, Lodge D (January 1986). "2-Methyl-3,3-diphenyl-3-propanolamine (2-MDP) selectively antagonises N-methyl-aspartate (NMA)". Pharmacology, Biochemistry, and Behavior. 24 (1): 23–25. doi:10.1016/0091-3057(86)90038-9. PMID 3511477. S2CID 29762524.
- ^ Biel JH (January 1967). Cain CK (ed.). "Antidepressants, Stimulants, Hallucinogens". Annual Reports in Medicinal Chemistry. 2. Academic Press: 11–23, 18. doi:10.1016/S0065-7743(08)61499-2.
- ^ Shipley GS, Bishop MP, Gallant DM (October 1967). "A controlled evaluation of U-23,807A in the neurotic depressive syndrome". Current Therapeutic Research, Clinical and Experimental. 9 (10): 514–516. PMID 4964946.
- ^ Moffett RB, Pickering TL (November 1971). "Central nervous system agents. 2. Synthesis of diphenyl primary and secondary aminopropanols". Journal of Medicinal Chemistry. 14 (11): 1100–1106. doi:10.1021/jm00293a019. PMID 5115211.
- v
- t
- e
(5-HT2A
agonists)
Benzofurans | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lyserg‐ amides |
| ||||||||||||||||||||||||||||||||||||||||
Phenethyl‐ amines |
| ||||||||||||||||||||||||||||||||||||||||
Piperazines | |||||||||||||||||||||||||||||||||||||||||
Tryptamines |
| ||||||||||||||||||||||||||||||||||||||||
Others |
|
(NMDAR
antagonists)
Arylcyclo‐ hexylamines |
| ||||||
---|---|---|---|---|---|---|---|
Adamantanes | |||||||
Diarylethylamines | |||||||
Morphinans | |||||||
Others |
(mAChR
antagonists)
- Atropine
- Benactyzine
- Benzatropine
- Benzydamine
- Biperiden
- BRN-1484501
- Brompheniramine
- BZ
- CAR-226,086
- CAR-301,060
- CAR-302,196
- CAR-302,282
- CAR-302,368
- CAR-302,537
- CAR-302,668
- Chloropyramine
- Chlorphenamine
- Clemastine
- CS-27349
- Cyclizine
- Cyproheptadine
- Dicycloverine
- Dimenhydrinate
- Diphenhydramine
- Ditran
- Doxylamine
- EA-3167
- EA-3443
- EA-3580
- EA-3834
- Flavoxate
- Hyoscyamine
- JB-318
- JB-336
- Meclozine
- Mepyramine
- Orphenadrine
- Oxybutynin
- Pheniramine
- Phenyltoloxamine
- Procyclidine
- Promethazine
- Scopolamine
- Tolterodine
- Trihexyphenidyl
- Tripelennamine
- Triprolidine
- WIN-2299
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e